ROCHE

ROCHE

Displaying 10 out of 26 results

  1. FILE PHOTO: FRITZ GERBER, CHAIRMAN OF THE BOARD OF ROCH, AT NEWS CONFERENCE.

    Fritz Gerber, who steered Roche from infamy to biotech success, dies at 91

    Fritz Gerber, the long-time head of Roche Holding who helped transform the Swiss company from an image-tarnished vitamins, drugs and chemicals ...
  2. FILE PHOTO: CEO Schwan of Swiss drugmaker Roche addresses news conference in Basel

    'A disaster': Roche CEO's verdict on some COVID-19 antibody tests

    Some blood tests being marketed to tell people if they have had the new coronavirus are a "disaster", Roche Chief Executive Severin Schwan said on ...
  3. FILE PHOTO: A scientist studies cancer cells inside white blood cells through a microscope at the G

    Drug developers take fresh aim at 'guided-missile' cancer drugs

    Dozens of drugmakers are conducting human trials for a record 89 therapies that pair antibodies with toxic agents to fight cancer, evidence of ...
  4. FILE PHOTO: Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

    Roche enters US$1.15 billion licensing deal for Sarepta gene therapy

    Roche entered into a US$1.15 billion licensing agreement with Sarepta Therapeutics to obtain the right to launch and commercialize Sarepta's ...
  5. FILE PHOTO: Swiss drugmaker Roche's logo is seen at their headquarters in Basel, Switzerland

    US approves Roche's US$4.3 billion purchase of Spark Therapeutics

    Swiss drugmaker Roche has won U.S. antitrust approval for its US$4.3 billion deal to buy gene therapy specialist Spark Therapeutics , the Federal ...
  6. FILE PHOTO: Swiss drugmaker Roche's logo is seen at their headquarters in Basel, Switzerland

    Roche's Tecentriq cocktail scores trial success in melanoma

    A late-stage clinical trial has shown therapy combining Roche's immunotherapy Tecentriq with two of its other drugs helped people with a form of ...
  7. FILE PHOTO: Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

    Roche wins FDA approval for immunotherapy cocktail against lung cancer

    Roche's Tecentriq immunotherapy mixed with chemotherapy won U.S. approval as an initial treatment for a form of lung cancer as the Swiss drugmaker ...